Men seeking a quick fix for erectile dysfunction, or ED, may be purchasing "dietary supplements" online that promise to improve their sexual potency but that actually could lower their blood pressure to dangerous levels, the FDA said in a July 12 news release.
FDA Warns Against Supplements for Erectile Dysfunction
By News Staff
Specifically, the FDA warned consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx or 4EVERON.
The products contain some ingredients or analogues of ingredients in drugs the FDA already has approved -- such as sildenafil, the active ingredient in Viagra, or vardenafil, the active ingredient in Levitra -- but the product labels of the so-called supplements do not list these ingredients, says the news release.
The products contain some ingredients or analogues of ingredients in drugs the FDA already has approved -- such as sildenafil, the active ingredient in Viagra, or vardenafil, the active ingredient in Levitra -- but the product labels of the so-called supplements do not list these ingredients, says the news release.
Sign Up for FDA E-Mail Alerts
Physicians who wish to receive FDA warnings via e-mail may visit the MedWatch E-List site and learn more about this service, including how to subscribe. MedWatch is the FDA’s safety information and adverse event reporting program. As part of the program’s e-list service, the FDA sends subscribers brief recaps of recent FDA safety alerts and public advisories about drugs and other medical products.
"This deception poses a threat to consumers because the undeclared ingredients may interact with nitrates found in some prescription drugs (such as nitroglycerin) and lower blood pressure to dangerous levels," says the release. "Consumers with diabetes, high blood pressure, high cholesterol or heart disease often take nitrates. ED is a common problem in men with these conditions."
The news release advises consumers to consult a health care professional before purchasing a product to treat ED.
The news release advises consumers to consult a health care professional before purchasing a product to treat ED.
Related News Story
MedWatch E-List Keeps Clinicians Informed
(7/28/2005)
Additional Resources
Recent FDA Warning Letter to Herbal Remedies Web Site
FDA 2004 Talk Paper on Actra-Rx
MedWatch E-List Keeps Clinicians Informed
(7/28/2005)
Additional Resources
Recent FDA Warning Letter to Herbal Remedies Web Site
FDA 2004 Talk Paper on Actra-Rx